Leucine, a building block of protein, attaches to a specific sensor in the brain. This attachment makes the brain send signals that increase the feeling of fullness and reduce how much food is eaten.
See the scientific wording
Leucine, an amino acid, binds to the CaV3.1 sensor in the brain, which triggers increased satiety and reduced food intake.
Backed by science
Mixed evidence2 low-scoring studies support this claim, so treat these as early signals rather than settled science.
What the research says
2 studies reviewedSupporting (2)
Randomized Controlled TrialHuman2018
Taking leucine made women feel fuller and less hungry, but the study didn't check if it acts through a specific brain sensor.
Case-Control StudyAnimal2026
The study shows that leucine, a protein building block, attaches to a specific brain sensor called CaV3.1, and this makes mice feel fuller and eat less, which matches the claim exactly.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Leucine is a building block of protein. When you eat protein, leucine goes to your brain. In the brain, there are special cells that control hunger. On these cells, there is a tiny door called CaV3.1. Leucine fits into this door and makes it open more easily. When the door opens, calcium comes into the cell. This calcium makes the cell send a signal to the brain that says 'I'm full'. So you feel full and eat less.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting studies
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Leucine, a building block of protein, attaches to a specific sensor in the brain. This attachment makes the brain send signals that increase the feeling of fullness and reduce how much food is eaten.
Mechanism
3 studiesLeucine from protein works in the brain by attaching to a special sensor on hunger-controlling cells. This makes the cells send a 'full' signal to the brain, so you feel full and eat less. There are other possible ways leucine might affect hunger, but the brain sensor is the most direct and clear-cut mechanism.
Leucine is a building block of protein. When you eat protein, leucine goes to your brain. In the brain, there are special cells that control hunger. On these cells, there is a tiny door called CaV3.1. Leucine fits into this door and makes it open more easily. When the door opens, calcium comes into the cell. This calcium makes the cell send a signal to the brain that says 'I'm full'. So you feel full and eat less.
Leucine binds to a hydrophobic pocket in the CaV3.1 voltage-gated calcium channel on POMC neurons in the hypothalamus.
This binding lowers the voltage threshold required for the channel to open, making it more likely to open at the neuron's resting membrane potential.
The opened channel allows calcium ions to flow into the POMC neuron, increasing intracellular calcium concentration.
The rise in calcium triggers activation of the POMC neuron, leading to the release of melanocortin peptides such as alpha-melanocyte-stimulating hormone (α-MSH).
These melanocortin peptides act on downstream receptors in the hypothalamus and brainstem to suppress appetite, reduce food intake, and increase energy expenditure.
Less supported by current evidence, but not ruled out
Leucine also makes the body release certain chemicals called cytokines that travel to the brain and help control hunger. These cytokines work independently of the CaV3.1 sensor.
Leucine triggers the release of pro-inflammatory cytokines such as IL-6 and IL-1β from immune cells or skeletal muscle.
Elevated IL-6 and IL-1β act on the hypothalamus to suppress appetite through vagal afferent signaling or direct transport across the blood-brain barrier.
Increased peptide YY (PYY) levels contribute to satiety by binding to Y2 receptors on appetite-stimulating (NPY/AgRP) neurons in the arcuate nucleus.
Evidence from Studies
Last searched 1mo ago
Supporting (2)
Community contributions welcome
Consuming Lower-Protein Nutrition Bars with Added Leucine Elicits Postprandial Changes in Appetite Sensations in Healthy Women.
Taking leucine made women feel fuller and less hungry, but the study didn't check if it acts through a specific brain sensor.
Cav3.1 is a neuronal leucine sensor that mediates satiety and weight loss in response to dietary protein
The study shows that leucine, a protein building block, attaches to a specific brain sensor called CaV3.1, and this makes mice feel fuller and eat less, which matches the claim exactly.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Randomized Controlled Trials on Leucine Supplementation for Satiety and Food Intake
Comprehensive search of RCTs comparing leucine supplementation (any dose) to placebo, measuring subjective satiety ratings and objective food intake, with follow-up of at least 4 weeks.
Double-Blind Placebo-Controlled Trial of Leucine Supplementation on Satiety and Food Intake in Healthy Adults
Randomized, double-blind, placebo-controlled trial with 100 healthy adults, receiving either 10g leucine/day or placebo for 8 weeks, measuring ad libitum food intake via weighed food diaries and satiety via visual analogue scales.
Prospective Cohort Study on Dietary Leucine Intake and Weight Change Over 5 Years
Prospective cohort of 10,000 adults with dietary intake assessed at baseline and annually, tracking weight and self-reported satiety over 5 years, controlling for confounders.
In Vitro Binding Assay of Leucine to CaV3.1 Channel in Brain Cells
Radioligand binding assay or surface plasmon resonance using recombinant CaV3.1 protein or neuronal cell lines, with competitive binding experiments to demonstrate specificity.
Animal Study of Leucine Administration on Feeding Behavior and Satiety in Mice
Randomized study in mice receiving intraperitoneal leucine or vehicle, measuring food intake over 24 hours and using knock-out mice for CaV3.1 to test if the effect is mediated by this channel.